MTEX Mannatech Inc.

Mannatech Brings TruHealthTM Fat-Loss System to Europe

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today launched its natural, plant-based TruHealth Weight-Loss System, to the European market. This breakthrough technology helps support healthy weight loss in order to help adults stay fit and transform their bodies from the inside out.1

This groundbreaking system offers three health and wellness products based on the company’s innovative glyconutritional technology. A thorough, 30-day program accompanies these products to support customers through a specialised nutrition and fitness transformation. This system combines beneficial, whole food diet recommendations with naturally sourced supplements and exercise to help support healthy weight loss for 30 days and beyond.

“Nearly all other companies and products focus on simple weight loss,” said Dr. Steve Nugent, Mannatech’s Senior Global Wellness Director and Chairman of the Mannatech Global Scientific Advisory Board. “This approach is too simplistic and may lead to an unhealthy body image. It typically encourages an unbalanced diet, provides unsustainable results and can involve the loss of lean muscle. Mannatech is leading a new weight loss charge by focusing on targeted weight loss and maintaining, if not increasing, muscle mass. Our system proves that it is not just about scale weight; it is about losing inches and getting truly healthy. We believe that you’ll look better and feel better with our revolutionary approach.”

Mannatech’s TruHealth System is comprised of three products to help support and nourish the body in order to lose weight in a safe and sustainable way.

  • TruPLENISHTM is a complete meal replacement drink full of vitamins, minerals, glyconutrients and more than 20 grams of plant-based protein. It also comes in delicious chocolate and vanilla flavors.
  • TruPURETM Slimsticks are an innovative nutritional drink mix, formulated with natural ingredients and vitamin B6, shown to support energy metabolism.2
  • TruSHAPETM Herbal Food Supplement capsules provide Capsicum extract to promote weight loss for a healthier and leaner looking physique.

“We are thrilled to bring the TruHealth System to Europe,” said Mannatech CEO and President, Alfredo “Al” Bala. “I personally have experienced incredible results from this programme, and I am excited that we can now provide these same great plant-based products to our European customers.”

The TruHealth Weight-Loss System is now available for purchase in the United Kingdom, Spain, Germany, Netherlands, Norway, Sweden, Ireland, Austria, Estonia, Finland and Czech Republic.

To begin changing your life or the lives of those around you, please visit Mannatech.com.

1 When taken in conjunction with a reduced calorie diet and regular exercise.

2 When one TruPURE slimstick is taken per day in conjunction with the TruHealth system recommendations (i.e., plentiful water intake, intake of healthy foods, elimination or low intake of processed foods, alcohol, caffeine, etc.)

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience that makes a difference in the lives of people across the world. Through its innovative Glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in more than 26 markets, Mannatech is committed to changing lives. For more information, visit Mannatech.com.

Please note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

EN
13/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

 PRESS RELEASE

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

 PRESS RELEASE

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

 PRESS RELEASE

Mannatech Reports Financial Results for First Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch